key: cord-0770658-okecht23
authors: Mehta, Nisha S; Mytton, Oliver T; Mullins, Edward W S; Fowler, Tom A; Falconer, Catherine L; Murphy, Orla B; Langenberg, Claudia; Jayatunga, Wikum J P; Eddy, Danielle H; Nguyen-Van-Tam, Jonathan S
title: SARS-CoV-2 (COVID-19): What do we know about children? A systematic review
date: 2020-05-11
journal: Clin Infect Dis
DOI: 10.1093/cid/ciaa556
sha: 8cfd2becd3b2b3aa12e339f64386726e69d982a8
doc_id: 770658
cord_uid: okecht23

BACKGROUND: Few paediatric cases of COVID-19 have been reported and we know little about the epidemiology in children, though more is known about other coronaviruses. We aimed to understand the infection rate, clinical presentation, clinical outcomes and transmission dynamics for SARS-CoV-2, in order to inform clinical and public health measures. METHODS: We undertook a rapid systematic review and narrative synthesis of all literature relating to SARS-CoV-2 in paediatric populations. The search terms also included SARS-CoV and MERS-CoV. We searched three databases and the COVID-19 resource centres of eleven major journals and publishers. English abstracts of Chinese language papers were included. Data were extracted and narrative syntheses conducted. RESULTS: 24 studies relating to COVID-19 were included in the review. Children appear to be less affected by COVID-19 than adults by observed rate of cases in large epidemiological studies. Limited data on attack rate indicate that children are just as susceptible to infection. Data on clinical outcomes are scarce but include several reports of asymptomatic infection and a milder course of disease in young children, though radiological abnormalities are noted. Severe cases are not reported in detail and there are little data relating to transmission. CONCLUSIONS: Children appear to have a low observed case rate of COVID-19 but may have similar rates to adults of infection with SARS-CoV-2. This discrepancy may be because children are asymptomatic or too mildly infected to draw medical attention, be tested and counted in observed cases of COVID-19.

In December 2019 reports emerged of a cluster of cases of pneumonia of unknown cause in Wuhan City, China, culminating in the identification of a novel coronavirus on 12 th January 2020, denoted as SARS-CoV-2, and the associated disease as COVID-19. [1] The virus spread rapidly around the world and was declared a pandemic by World Health Organization (WHO) on 11 th March 2020, [2] with many countries adopting unprecedented public health measures to curb its spread.

Coronaviruses are large, lipid-enveloped, single-stranded RNA viruses found in avian and mammalian species. Human coronaviruses commonly cause mild upper respiratory tract infections, accounting for about 30% of common colds, although instances of severe disease are described in the elderly, children and immunocompromised hosts. [3] Besides SARS-CoV-2, there are two other notable exceptions: Severe Acute Respiratory Syndrome coronavirus (SARS-CoV) and Middle East Respiratory Syndrome coronavirus (MERS-CoV). An epidemic of SARS-CoV in 2003 affected 26 countries and resulted in more than 8000 cases and 774 deaths. [4] MERS-CoV was first reported in 2012, and is now endemic at low levels in the Persian Gulf region, with notable nosocomial outbreaks but otherwise limited human-human transmission. [5] As of 19 th November 2019, WHO has reported 2494 cases and 858 deaths. [5] The respective R0 values for SARS-CoV, MERS-CoV and SARS-CoV-2 (outside nosocomial outbreaks) are 3, [4] <1, [6] and 2-3. [7] Social distancing policies have been widely adopted in many countries to limit spread of SARS-CoV-2, at great economic and social cost. Social-distancing policies that apply to children, such as school closures, may have an important role in mitigating the spread of pandemics; for many infectious diseases, such as influenza, children are known to drive transmission in households and communities. However, early reports of SARS-CoV-2, [1] as well as MERS-CoV and SARS-CoV, suggest that children are less likely to be infected and to develop serious disease compared to adults.

A c c e p t e d M a n u s c r i p t 6 We undertook a narrative review of the emerging literature on SARS-CoV-2 to summarise current understanding of the epidemiology and transmission dynamics of this coronavirus in children, in order to inform decisions regarding clinical and public health measures for children in the UK.

We searched MEDLINE, MedRxiv and the COVID-19 literature resources of WHO and major journals, for all English-language papers concerning SARS-CoV, SARS-CoV-2 or MERS-CoV, in children, up to 9 th March 2020. Inclusion criteria were any study or article that included information about infection risk, transmission or severity in children (aged under 18 years) for SARS-CoV-2. All types of study and countries of origin were eligible for inclusion. Our broader search also identified papers relating to SARS-CoV and MERS-CoV, to allow for informative comparison, though this was not the focus of the A c c e p t e d M a n u s c r i p t 7 review. We excluded articles that exclusively reported data on adults or other respiratory viruses, that did not relate to the clinical or epidemiological aspects of interest, and that were not written in the English language. Eight reviewers extracted data on infection risk, transmission, and clinical presentation and outcomes, into a cloud-based spreadsheet (Google Sheets). We also recorded the case definition, the type of study or report and important limitations, though quality was not formally assessed, and findings were synthesised narratively. As this was a rapid review, each paper was reviewed by one reviewer.

Our search retrieved 1657 records, of which 1552 were excluded via title and abstract screen. 105 full articles were assessed for eligibility and 77 were identified relating to SARS-CoV, MERS-CoV and SARS-CoV-2. Of these, 24 papers relating to SARS-CoV-2 were identified, from which data were extracted and synthesised (see Figure 1 ). 16 of the included papers were pre-prints or reports not certain to have been subjected to peer review. All COVID-19 papers drew heavily or exclusively on data and experience from China. A summary of the included papers is provided in Table 1. A c c e p t e d M a n u s c r i p t cases were in children aged in 0-10 years old, and 31 cases (2.7%) in children aged 11-20 years old.

The youngest patient identified was 28 days old, with several cases reported in neonates. [9] 'Report of the WHO-China Joint Mission on COVID-19' [7] concludes that 'we cannot determine the extent of infection among children, what role children play in transmission, whether children are less susceptible or whether they simply present differently'.

In an early epidemiological analysis of 507 COVID-19 cases, mainly from China, 13 (2.6%) were younger than 15 years, and the relative risk of COVID-19 in children was less than 0.5 compared to the population average. [10] In contrast, a follow-up study of 1286 close contacts of 391 confirmed cases reported in Shenzhen province, China, reported a similar infection rate (7.4%) in children under 10 years of age (n=148) and aged 11-19 years (7.1%) (n=84) to the population average (7.9%).

The close contact cases amongst children were less likely to be severe and less likely to present with fever compared to adults, demonstrating how milder clinical presentation may lead to undercounting of cases. [11] A c c e p t e d M a n u s c r i p t

Symptoms of COVID-19 are nonspecific and disease presentation ranges from asymptomatic to severe pneumonia and death. [7] Evidence so far suggests a milder course of disease in children, and some asymptomatic cases, but with evidence of radiological lung changes in both categories. Cai et al [12] reported a case series of 10 paediatric patients (aged 3 months-10 years) with confirmed SARS-CoV-2 infection from four cities in China in February 2020. The symptoms reported were fever (8 patients), cough (6), sore throat (4), nasal congestion (3) and sneezing and rhinorrhoea (2) . None of the patients had dyspnoea or diarrhoea during the illness, and fever resolved after 24 hours.

Chest X-Ray revealed unilateral patchy infiltrate in four of ten patients. Wei et al [9] identified all hospitalised infants in China diagnosed with COVID-19 infection between 8 th December 2019 and 6 th February 2020. Nine infected infants were identified (age range 1-11 months) with symptoms reported as fever (4 infants), mild upper respiratory tract symptoms (2) , no symptoms (1) and two with no information on symptoms available. None required intensive care or mechanical ventilation.

Asymptomatic infection in children is reported in 14 individual cases, reported in five separate papers. [9, [13] [14] [15] [16] Notably, in an early report [13] of a familial cluster in China, an asymptomatic 10-

year-old boy was screened as part of the family cluster and CT chest revealed radiological ground glass lung opacities. In Singapore, a well six-month-old infant with COVID-19 and high viral load was detected as part of a cluster and was also asymptomatic throughout admission. [15] Asymptomatic cases are also reported in the English abstract of a Chinese paper which reports clinical data and CT chest images of 15 children (aged 4-14 years old) diagnosed with COVID-19 in Shenzhen. Five children were febrile and 10 asymptomatic on first visit. The abstract reports radiological changes which are difficult to interpret: 'For their first chest CT images, six patients had no lesions, while nine A c c e p t e d M a n u s c r i p t 10 patients had pulmonary inflammation lesions. Seven cases of small nodular ground glass opacities and two cases of speckled ground glass opacities were found.' [16] Clinical Outcomes Whilst most symptomatic cases in children are described as mild, severe cases of the disease have been reported. 'Report of the WHO-China Joint Mission on COVID-19' stated that 2.5% of the cases amongst those under 19 years old were severe, and 0.2% were critical. [7] Amongst the 105 children admitted to Wuhan's Children's Hospital, the sole hospital for treating COVID-19 in children in Wuhan, eight (7.6%) were reported to have severe disease. [17] Amongst the large analysis of 72,314 cases from China, there were no deaths reported amongst the 416 reported cases in children aged 1-9 years, and a single death amongst the 549 cases in children aged 10-19 years. This equates to a case fatality rate of 0.2% in those aged 10-19 years. [18] Co-morbidities There is a suggestion that children with underlying conditions are at greater risk of infection or more severe disease, although the evidence is limited and mixed. Among 31 paediatric cases of SARS-CoV-2 (12 asymptomatic and 19 described as mild) outside Wuhan, only two were reported to have underlying conditions (one had asthma, one had a duplicate kidney). [19] Among a series of 20 paediatric patients treated at Wuhan Children's Hospital, seven were reported as having underlying conditions, though these were not specified. [20] There were no data on underlying conditions from the larger cases series of children from Wuhan Children's Hospital (n=105). [17] While underlying conditions were noted to be an important risk A c c e p t e d M a n u s c r i p t 11 factor in the overall population (particularly respiratory and cardiovascular disease), no paediatric specific data on underlying conditions were presented in the major analyses of Chinese data. [7, 18] Transmission There is limited evidence relating to transmission of SARS-CoV-2 by children. Many of the childhood cases are from familial clusters, with the children tending to be identified through contact tracing of adult cases. [6, 9, 20, 21] Whilst people interviewed by the WHO-China Joint Mission could not recall episodes of a child infecting an adult (or another child), [7] there has subsequently been one clinical report of probable transmission from a 3-month-old infant to her parents. Both parents developed symptomatic COVID-19 days after they looked after the sick baby without personal protective measures. [12] A c c e p t e d M a n u s c r i p t 12

In this study we have reviewed the early data on the likelihood of infection, clinical presentation and outcomes, and transmission of COVID-19 in children. The majority of data were from China, and may be subject to ascertainment bias, either due to a higher than known proportion of milder cases in both adults and children, or due to selective ascertainment and testing bias towards adults with acute respiratory symptoms and limitations in diagnostic capacity. A number of the studies examined are pre-prints and have not been subjected to peer-review.

Nevertheless, we identify that children appear to be less affected by COVID-19 than adults by observed rate of infection; while 17.8% of the population were aged 0-15 years old, only 2.1% of reported cases in a large case series from China were in the 0-19 age group. [22] However, a preprint paper [11] reports that children under 10 who were potentially exposed to the virus were just as likely to become infected as other age groups in the population. Low observed rates of infection and similar susceptibility to infection could be explained by differences in symptomatic infection rates. Other factors may have included social distancing methods, such as school closures. It should also be noted that the age profile of the population in China is unusual, in that few children will have siblings, but will usually have two parents and up to four grandparents. Critically, serological data are missing at this stage in the pandemic, without which uncertainty about infection rates is likely to persist.

Reliable evidence about clinical features and outcomes of COVID-19 in children is limited to small case series and case reports. Key emerging themes from the literature include description of generally mild symptoms [12] and several reports of asymptomatic infections, [9, [13] [14] [15] [16] with some indication from a case series of 105 children in Wuhan that there have been severe cases (7.6%). [17] Rarely, paediatric deaths have also been reported. [18] We found no detailed studies of transmission of SARS-CoV-2 from children. Many of the childhood cases are from familial clusters with children A c c e p t e d M a n u s c r i p t 13 identified through contact tracing of adult cases. [19, 20] There is only one case describing likely transmission from a 3-month-old infant to her parents after they looked after the unwell infant without personal protective measures. [12] Of note is the high frequency of chest radiographic abnormality described in both mild and asymptomatic infections in children. Longitudinal data will be required to understand the duration, persistence and functional deficit related to these findings.

We detected only a weak signal that children with comorbidities are at increased risk or are overrepresented among paediatric COVID-19 cases. This is broadly in line with a review of 14 paediatric MERS cases of whom nine without underlying disease remained healthy and three developed mild respiratory symptoms; the remaining two cases had significant comorbidities, developed severe respiratory symptoms, were treated in intensive care and subsequently died.

Given that poor COVID-19 outcomes have been seen in adults with underlying conditions, a similar issue in children might be anticipated when sufficient data are available. Typically, a paediatric population may contain about 10% of children with one or more of the following: prematurity with chronic lung disease; cancer; genetic conditions such as cystic fibrosis and alpha 1 antitrypsin deficiency; chronic asthma and mucosal immune defects. [23] More evidence is therefore needed about clinical features and outcomes in children with high-risk conditions. So far there has been only one documented case of transmission of SARS-CoV-2 from a child to an adult, though if infection rates are as high in children as in adults, as described by Bi et al, [11] it would be highly implausible that children were not infecting adults in a more widespread way. The WHO-China Joint Mission was unable to shed any light on this beyond anecdotally reporting no transmission from children. [7] One study attempts to assess the impact of Hong Kong's public health measures and population behaviour change on COVID-19 transmission, using routine influenza surveillance data as a proxy, assuming that influenza and COVID-19 are likely transmitted in similar ways.

[24] The authors demonstrate the substantial impact that familiar public health measures 

A c c e p t e d M a n u s c r i p t M a n u s c r i p t Clinical presentation: Common symptoms were fever (n=20, 65%), including 1 case of high fever, 9 cases of moderate fever, 10 cases of low fever.

M a n u s c r i p t Clinical presentation: None reported. Imaging had fully resolved in 3 out of the 4 children.

Transmission: None reported.

Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia

World Health Organization. Coronavirus disease 2019 (COVID-19) Situation Report -51. World Health Organization

Noninfluenza Respiratory Viruses

World Health Organization, Department of Communicable Disease Surveillance and Response. Consensus document on the epidemiology of severe acute respiratory syndrome (SARS). World Health Organization

Middle East respiratory syndrome coronavirus (MERS-CoV), MERS Monthly Summary

High reproduction number of Middle East respiratory syndrome coronavirus in nosocomial outbreaks: mathematical modelling in Saudi Arabia and South Korea

Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19)

Epidemiological characteristics of 1212 COVID-19 patients in Henan

Novel Coronavirus Infection in Hospitalized Infants Under 1 Year of Age in China

Early epidemiological analysis of the coronavirus disease 2019 outbreak based on crowdsourced data: a population-level observational study. Lancet Digit Heal

Epidemiology and Transmission of COVID-19 in Shenzhen China: Analysis of 391 cases and 1,286 of their close contacts. medRxiv Prepr

A case series of children with 2019 novel coronavirus infection: clinical and epidemiological features

A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster

Asymptomatic cases in a family cluster with SARS-CoV-2 infection

A Well Infant with Coronavirus Disease 2019 (COVID-19) with High Viral Load

Analysis of CT features of 15 Children with 2019 novel coronavirus infection

Data-driven discovery of clinical routes for severity detection in COVID-19 pediatric cases

The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team Vital Surveillances: The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) -China

Coronavirus Disease-19 Among Children outside Wuhan, China

Clinical and CT features in pediatric patients with COVID-19 infection: Different points from adults

Coronavirus disease (COVID-19) and neonate: What neonatologist need to know

Population distribution in China in 2019, by broad age group

The Partnership for Maternal, Newborn & Child Health, Save The Children, World Health Organization

A c c e p t e d M a n u s c r i p t 29 laboratory-confirmed children. 21